RBFOX3 and Stroke: As shown in Figure 11A(a-f), when administered one week after PT stroke, cTBS treatment (last for 6 days) also significantly enhanced the counts of NeuN+/BrdU+ cells, suggesting that both early and late application of cTBS is effective in promoting post-stroke neurogenesis.